港股異動丨網易跌近3%,Q4營收同比下降1.3%,遜預期
昨晚公佈財報的網易-S(9999.HK)盤初一度跌2.78%,報153.7港元,爲連續第三日下跌,股價創1月23日以來新低。隔夜美股網易收跌2.64%報101.42美元,折算成港股市場價格爲155.49港元/股。網易財報顯示:四季度淨營業收入267.5億元,同比下降1.3%,且低於分析師預估的272.5億元(未能如分析師預期轉增);毛利潤162.7億元,同比下降,且低於分析師預估的166.9億元;淨利潤89.2億元,止跌回升,同比增長33.6%,環比增長33%,淨利潤遠超預期得益於營銷費用銳減。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.